These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
334 related articles for article (PubMed ID: 29689379)
21. Should minimal residual disease guide therapy in AML? Paietta E Best Pract Res Clin Haematol; 2015; 28(2-3):98-105. PubMed ID: 26590765 [TBL] [Abstract][Full Text] [Related]
22. Monitoring of minimal residual disease by quantitative WT1 gene expression following reduced intensity conditioning allogeneic stem cell transplantation in acute myeloid leukemia. Candoni A; Toffoletti E; Gallina R; Simeone E; Chiozzotto M; Volpetti S; Fanin R Clin Transplant; 2011; 25(2):308-16. PubMed ID: 20412098 [TBL] [Abstract][Full Text] [Related]
23. Minimal residual disease monitoring based on FLT3 internal tandem duplication in adult acute myeloid leukemia. Abdelhamid E; Preudhomme C; Helevaut N; Nibourel O; Gardin C; Rousselot P; Castaigne S; Gruson B; Berthon C; Soua Z; Renneville A Leuk Res; 2012 Mar; 36(3):316-23. PubMed ID: 22129478 [TBL] [Abstract][Full Text] [Related]